Medicare “Phases In” Changes To Claims Appeals Process, Starting In May
This article was originally published in The Gray Sheet
Executive Summary
At least four Medicare-contracted entities will provide a second level of appeals for beneficiaries seeking to overturn claims redeterminations that carriers issue after December
You may also be interested in...
Medicare Appeals Rule Expedited By Visudyne Settlement; MCAC To Convene
CMS' Medicare Coverage Advisory Committee will review initial data from QLT, Inc.'s Phase III trial investigating Visudyne (verteporfin) ocular photodynamic therapy in age-related macular degeneration patients with occult lesions
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.